For the past year, a novel Israeli medical device has been changing the way American doctors remove fibro-adenoma tumors – benign breast lumps. Now an internationally renowned Japanese surgeon is testing IceSense3, made in Israel by IceCure Medical, to destroy small malignant tumors as well.
“This is the future,” CEO Hezi Himelfarb tells ISRAEL21c.
During an ultrasound-guided procedure, the IceSense3 probe penetrates the tumor and destroys it by engulfing it with ice. Needing only local anesthetic, the cryoablation process takes five or 10 minutes in a doctor’s office, clinic or breast center, and the patient can get up and leave afterward. No recovery period or post-care is necessary.
Dr. Eisuke Fukuma, chairman of the Breast Center at Kameda Medical Center in Kamogawa City, Japan, was so intrigued by IceSense3’s potential in this area that he flew all the way to IceCure’s Caesarea headquarters just for a four-hour meeting to lay the groundwork for clinical trials at his center.
On June 1, the first four patients in the trial had small tumors successfully destroyed with the device, and another 26 patients are scheduled.
“This procedure is an exciting step towards moving treatment of small, early-stage breast cancer tumors from open surgery to a minimally invasive cryoablation procedure,” Fukuma stated. “Cryoablation offers a much more comfortable and cosmetically appealing treatment option for small breast cancers.”
Israel Seen – “I Am Not Orthodox” and “Final Prayer”
38 minutes ago